Lantheus Holdings (LNTH) EPS (Weighted Average and Diluted) (2015 - 2026)
Lantheus Holdings (LNTH) reported EPS (Weighted Average and Diluted) of $1.8 for Q1 2026, up 76.47% year-over-year from $1.02 in Q1 2025, and up 122.22% quarter-over-quarter from $0.81 in Q4 2025.
Lantheus Holdings (LNTH) EPS (Weighted Average and Diluted) (2015 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 12 years of EPS (Weighted Average and Diluted) data on file, last reported at $1.8 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at $1.8, up 76.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.14 (up 18.29% YoY), and the FY2025 annual result was $3.41, down 21.79% from the prior year.
- EPS (Weighted Average and Diluted) rose to $1.8 in Q1 2026 per LNTH's latest filing, from $0.81 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $1.88 in Q3 2023 and troughed at -$1.68 in Q4 2022.
- A 5-year average of $0.86 and a median of $0.88 in 2024 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2022 and 2024: EPS (Weighted Average and Diluted) tumbled 180.0% in 2022, then soared 4775.0% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$1.68 in 2022, then soared by 187.5% to $1.47 in 2023, then plunged by 112.93% to -$0.19 in 2024, then surged by 526.32% to $0.81 in 2025, then surged by 122.22% to $1.8 in 2026.
- Business Quant data shows LNTH's EPS (Weighted Average and Diluted) at $1.8 in Q1 2026, $0.81 in Q4 2025, and $0.41 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 0.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.80 |
| Dec 31, 2025 | 0.81 |
| Sep 30, 2025 | 0.41 |
| Jun 30, 2025 | 1.12 |
| Mar 31, 2025 | 1.02 |
| Dec 31, 2024 | -0.19 |
| Sep 30, 2024 | 1.79 |
| Jun 30, 2024 | 0.88 |
| Mar 31, 2024 | 1.87 |
| Dec 31, 2023 | 1.47 |
| Sep 30, 2023 | 1.88 |
| Jun 30, 2023 | 1.33 |
| Mar 31, 2023 | -0.04 |
| Dec 31, 2022 | -1.68 |
| Sep 30, 2022 | 0.86 |
| Jun 30, 2022 | 0.61 |
| Mar 31, 2022 | 0.61 |
| Dec 31, 2021 | -0.60 |
| Sep 30, 2021 | -0.20 |
| Jun 30, 2021 | -0.39 |